| |
| | | Cervical cancer: ESMO Clinical Recommendations for diagnosis, treatment and follow-up Ann Oncol 19: ii17-ii18; doi:10.1093/annonc/mdn112 http://annonc.oxfordjournals.org/cgi/reprint/19/suppl_2/ii17 | |
| |
| | | Endometrial carcinoma: ESMO Clinical Recommendations for diagnosis, treatment and follow-up Ann Oncol 19: ii19-ii20; doi:10.1093/annonc/mdm113 http://annonc.oxfordjournals.org/cgi/reprint/19/suppl_2/ii19 | |
|
|
|
Esophageal cancer: ESMO Clinical Recommendations for
diagnosis, treatment and follow-up
Ann Oncol 19: ii21-ii22; doi:10.1093/annonc/mdm074
http://annonc.oxfordjournals.org/cgi/reprint/19/suppl_2/ii21 |
|
|
|
|
Gastric cancer: ESMO Clinical Recommendations for diagnosis, treatment
and follow-up
Ann Oncol 19: ii23-ii24; doi:10.1093/annonc/mdm075
http://annonc.oxfordjournals.org/cgi/reprint/19/suppl_2/ii23
|
|
|
| |
|
Pancreatic cancer: ESMO Clinical Recommendations for diagnosis,
treatment and follow-up
Ann Oncol 19: ii25-ii26; doi:10.1093/annonc/mdm076
http://annonc.oxfordjournals.org/cgi/reprint/19/suppl_2/ii25 |
|
| |
| | | Hepatocellular carcinoma: ESMO Clinical Recommendations for diagnosis, treatment
and follow-up Ann Oncol 19: ii27-ii28; doi:10.1093/annonc/mdm114 http://annonc.oxfordjournals.org/cgi/reprint/19/suppl_2/ii27
| |
|
| |
|
Colon cancer: ESMO Clinical Recommendations for diagnosis, adjuvant
treatment and follow-up
Ann Oncol 19: ii29-ii30; doi:10.1093/annonc/mdm077
http://annonc.oxfordjournals.org/cgi/reprint/19/suppl_2/ii29
|
|
|
| |
|
Rectal cancer: ESMO Clinical Recommendations for diagnosis, treatment
and follow-up
Ann Oncol 19: ii31-ii32; doi:10.1093/annonc/mdm078
http://annonc.oxfordjournals.org/cgi/reprint/19/suppl_2/ii31
|
|
|
| |
|
Advanced colorectal cancer: ESMO Clinical Recommendations for diagnosis,
treatment and follow-up
Ann Oncol 19: ii33-ii34; doi:10.1093/annonc/mdm079
http://annonc.oxfordjournals.org/cgi/reprint/19/suppl_2/ii33 |
|
|
| |
|
Gastrointestinal stromal tumors: ESMO Clinical Recommendations for
diagnosis, treatment and follow-up
Ann Oncol 19: ii35-ii38; doi:10.1093/annonc/mdm080
http://annonc.oxfordjournals.org/cgi/reprint/19/suppl_2/ii35 |
|
|
| |
|
Non-small-cell lung cancer: ESMO Clinical Recommendations for diagnosis,
treatment and follow-up
Ann Oncol 19: ii39-ii40; doi:10.1093/annonc/mdm081
http://annonc.oxfordjournals.org/cgi/reprint/19/suppl_2/ii39 |
|
|
| |
|
Small-cell lung cancer: ESMO Clinical Recommendations for diagnosis,
treatment and follow-up
Ann Oncol 19: ii41-ii42; doi:10.1093/annonc/mdm082
http://annonc.oxfordjournals.org/cgi/reprint/19/suppl_2/ii41 |
|
|
| |
|
Malignant pleural mesothelioma: ESMO Clinical Recommendations for
diagnosis, treatment and follow-up
Ann Oncol 19: ii43-ii44; doi:10.1093/annonc/mdm083
http://annonc.oxfordjournals.org/cgi/reprint/19/suppl_2/ii43 |
|
|
| |
|
Prostate cancer: ESMO Clinical Recommendations for diagnosis, treatment
and follow-up
Ann Oncol 19: ii45-ii46; doi:10.1093/annonc/mdm084
http://annonc.oxfordjournals.org/cgi/reprint/19/suppl_2/ii45 |
|
|
| |
|
Invasive bladder cancer: ESMO Clinical Recommendations for diagnosis, treatment
and follow-up
Ann Oncol 19: ii47-ii48; doi:10.1093/annonc/mdm085
http://annonc.oxfordjournals.org/cgi/reprint/19/suppl_2/ii47 |
|
|
| |
|
Testicular seminoma: ESMO Clinical Recommendations for diagnosis,
treatment and follow-up
Ann Oncol 19: ii49-ii51; doi:10.1093/annonc/mdm086
http://annonc.oxfordjournals.org/cgi/reprint/19/suppl_2/ii49 |
|
|
| |
|
Mixed or non-seminomatous germ-cell tumors: ESMO Clinical Recommendations
for diagnosis, treatment and follow-up
Ann Oncol 19: ii52-ii54; doi:10.1093/annonc/mdm087
http://annonc.oxfordjournals.org/cgi/reprint/19/suppl_2/ii52 |
|
|
| |
|
Multiple myeloma: ESMO Clinical Recommendations for diagnosis, treatment
and follow-up
Ann Oncol 19: ii55-ii57; doi:10.1093/annonc/mdm088
http://annonc.oxfordjournals.org/cgi/reprint/19/suppl_2/ii55 |
|
|
| |
|
Acute myeloblastic leukemia in adult patients: ESMO Clinical
Recommendations for diagnosis, treatment and follow-up
Ann Oncol 19: ii58-ii59; doi:10.1093/annonc/mdm089
http://annonc.oxfordjournals.org/cgi/reprint/19/suppl_2/ii58
|
|
|
| |
|
Chronic lymphocytic leukemia: ESMO Clinical Recommendations for
diagnosis, treatment and follow-up
Ann Oncol 19: ii60-ii62; doi:10.1093/annonc/mdm090
http://annonc.oxfordjournals.org/cgi/reprint/19/suppl_2/ii60 |
|
|
| |
|
Chronic myelogenous leukemia: ESMO Clinical Recommendations for
diagnosis, treatment and follow-up
Ann Oncol 19: ii63-ii64; doi:10.1093/annonc/mdm091
http://annonc.oxfordjournals.org/cgi/reprint/19/suppl_2/ii63
|
|
|
| |
|
Hodgkin's lymphoma: ESMO Clinical Recommendations for diagnosis,
treatment and follow-up
Ann Oncol 19: ii65-ii66; doi:10.1093/annonc/mdm092
http://annonc.oxfordjournals.org/cgi/reprint/19/suppl_2/ii65 |
|
|
| |
|
Diffuse large B-cell non-Hodgkin's lymphoma: ESMO Clinical
Recommendations for diagnosis, treatment and follow-up
Ann Oncol 19: ii67-ii69; doi:10.1093/annonc/mdm093
http://annonc.oxfordjournals.org/cgi/reprint/19/suppl_2/ii67 |
|
|
| |
|
Gastric marginal zone lymphoma of MALT type: ESMO Clinical Recommendations for diagnosis, treatment
and follow-up
Ann Oncol 19: ii70-ii71; doi:10.1093/annonc/mdm094
http://annonc.oxfordjournals.org/cgi/reprint/19/suppl_2/ii70 |
|
|
| |
|
Primary cutaneous lymphomas: ESMO Clinical
Recommendations for diagnosis, treatment and follow-up
Ann Oncol 19: ii72-ii76; doi:10.1093/annonc/mdm095
http://annonc.oxfordjournals.org/cgi/reprint/19/suppl_2/ii72 |
|
|
| |
|
Newly diagnosed and relapsed follicular lymphoma: ESMO Clinical
Recommendations for diagnosis, treatment and follow-up
Ann Oncol 19: ii77-ii78; doi:10.1093/annonc/mdm096
http://annonc.oxfordjournals.org/cgi/reprint/19/suppl_2/ii77 |
|
|
| |
|
Squamous cell carcinoma of the head and neck: ESMO
Clinical Recommendations for diagnosis, treatment and follow-up
Ann Oncol 19: ii79-ii80; doi:10.1093/annonc/mdm097
http://annonc.oxfordjournals.org/cgi/reprint/19/suppl_2/ii79 |
|
|
| |
|
Nasopharyngeal cancer: ESMO Clinical Recommendations
for diagnosis, treatment and follow-up
Ann Oncol 19: ii81-ii82; doi:10.1093/annonc/mdm098
http://annonc.oxfordjournals.org/cgi/reprint/19/suppl_2/ii81 |
|
|
| |
|
Malignant glioma: ESMO Clinical Recommendations for
diagnosis, treatment and follow-up
Ann Oncol 19: ii83-ii85; doi:10.1093/annonc/mdm099
http://annonc.oxfordjournals.org/cgi/reprint/19/suppl_2/ii83 |
|
|
|
|
Cutaneous malignant melanoma: ESMO Clinical
Recommendations for diagnosis, treatment and follow-up
Ann Oncol 19: ii86-ii88; doi:10.1093/annonc/mdm100
http://annonc.oxfordjournals.org/cgi/reprint/19/suppl_2/ii86 |
|
|
| |
|
Soft tissue sarcomas: ESMO Clinical Recommendations
for diagnosis, treatment and follow-up
Ann Oncol 19: ii89-ii93; doi:10.1093/annonc/mdm101
http://annonc.oxfordjournals.org/cgi/reprint/19/suppl_2/ii89 |
|
|
| |
|
Osteosarcoma: ESMO Clinical Recommendations for
diagnosis, treatment and follow-up
Ann Oncol 19: ii94-ii96; doi:10.1093/annonc/mdm102
http://annonc.oxfordjournals.org/cgi/reprint/19/suppl_2/ii94 |
|
|
|
|
Ewing's sarcoma of bone:
ESMO Clinical Recommendations for diagnosis, treatment and follow-up
Ann Oncol 19: ii97-ii98; doi:10.1093/annonc/mdm103
http://annonc.oxfordjournals.org/cgi/reprint/19/suppl_2/ii97
|
|
| |
| | | Differentiated thyroid cancer: ESMO Clinical Recommendations for diagnosis, treatment and follow-up
Ann Oncol 19: ii99-ii101; doi:10.1093/annonc/mdm115 http://annonc.oxfordjournals.org/cgi/reprint/19/suppl_2/ii99 | |
| |
| | | Neuroendocrine bronchial and thymic tumors: ESMO Clinical Recommendations for diagnosis, treatment and follow-up Ann Oncol 19: ii102-ii103; doi:10.1093/annonc/mdm116 http://annonc.oxfordjournals.org/cgireprint/19/suppl_2/ii102 | |
| |
| | | Neuroendocrine gastroenteropancreatic tumors: ESMO Clinical Recommendations for diagnosis, treatment and follow-up
Ann Oncol 19: ii104-ii105; doi:10.1093/annonc/mdm117 http://annonc.oxfordjournals.org/cgi/reprint/19/suppl_2/ii104 | |
| |
| |
|
Cancers of unknown primary
site: ESMO Clinical Recommendations for diagnosis, treatment and follow-up
Ann Oncol 19: ii106-ii107; doi:10.1093/annonc/mdm104
http://annonc.oxfordjournals.org/cgi/reprint/19/suppl_2/ii106 |
|
| |
| | | Cancer, fertility and pregnancy: ESMO Clinical Recommendations for diagnosis, treatment and follow-up Ann Oncol 19: ii108-ii109; doi:10.1093/annonc/mdm118 http://annonc.oxfordjournals.org/cgi/reprint/19/suppl_2/ii108 | |
| |
| |
|
Chemotherapy-induced
nausea and vomiting: ESMO Clinical Recommendations for prophylaxis
Ann Oncol 19: ii110-ii112; doi:10.1093/annonc/mdm105
http://annonc.oxfordjournals.org/cgi/reprint/19/suppl_2/ii110 |
|
| |
|
Erythropoietins in cancer patients: ESMO Recommendations for use Ann Oncol 19: ii113-ii115; doi 10.1093/annonc/mdm106 http://annonc.oxfordjournals.org/cgi/reprint/19/suppl_2/ii113
|
|
| |
| |
|
Hematopoietic growth
factors: ESMO Recommendations for the applications
Ann Oncol 19: ii116-ii118; doi:10.1093/annonc/mdm107
http://annonc.oxfordjournals.org/cgi/reprint/19/suppl_2/ii116 |
|
| |
| |
|
Management of cancer pain: ESMO Clinical Recommendations
Ann Oncol 19: ii119-ii121; doi:10.1093/annonc/mdm108
http://annonc.oxfordjournals.org/cgi/reprint/19/suppl_2/ii119
|
|
| |
| | | Management of oral and gastrointestinal mucositis: ESMO Clinical Recommendations Ann Oncol 19: ii122-ii125; doi:10.1093/annonc/mdm109 http://annonc.oxfordjournals.org/cgi/reprint/19/suppl_2/ii122 | |
| |
| | | Management of venous thromboembolism in cancer patients: ESMO Clinical Recommendations Ann Oncol 19: ii126-ii127; doi:10.1093/annonc/mdm110 http://annonc.oxfordjournals.org/cgi/reprint/19/suppl_2/ii126 | |